Danny Phillips's most recent trade in Caris Life Sciences Inc. - Ordinary Shares - Class A was a trade of 3,739 Common Stock done at an average price of $20.1 . Disclosure was reported to the exchange on Feb. 26, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Caris Life Sciences Inc (Class A) | Danny Phillips | Director | Grant, award, or other acquisition of securities at price $ 20.06 per share. | 26 Feb 2026 | 3,739 | 119,868 | - | 20.1 | 75,004 | Common Stock |
| Caris Life Sciences Inc (Class A) | Danny Phillips | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2025 | 100,000 | 0 | - | - | Stock Option | |
| Caris Life Sciences Inc (Class A) | Danny Phillips | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.44 per share. | 11 Sep 2025 | 100,000 | 116,129 | - | 2.4 | 244,000 | Common Stock |